Published in Gene Therapy Weekly, May 6th, 2010
"QPCR showed PPAR gamma to be expressed in the hypothalamus at this developmental stage. Intracerebral injection of PPAR gamma agonists modified transcription from a TRH-luc construct introduced into the hypothalamus and increased serum thyroxine levels. Furthermore shRNA-based in vivo, PPAR gamma knockdown...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.